NewsHK
Pomerantz LLP announced on June 18, 2026, that it is investigating claims on behalf of investors of TriSalus Life Sciences Inc., the Nasdaq-listed company trading under the ticker TLSI.
The New York-based law firm advised investors in TriSalus to contact the firm to learn more about their potential rights and remedies.
The Investigation The inquiry was disclosed by Pomerantz LLP, a firm that specialises in securities class action litigation.
The announcement identified Danielle Peyton as the point of contact for investors seeking information, reachable at newaction@pomlaw.com or by telephone at 646-581-9980, extension 7980.
Keep reading